Therakos is a medical device company pioneering extracorporeal photopheresis (ECP) immunomodulation therapy. Founded in 1984 and headquartered in Bridgewater, New Jersey, Therakos develops the THERAKOS Photopheresis System used in the treatment of cutaneous T-cell lymphoma (CTCL) and other immune-mediated diseases. The company operates globally with offices in the United States, Ireland and the United Kingdom.